Fundraising Fox

Pivot Bio

Emeryville, US · Founded 2011 · Delaware corporation · 307 employees on LinkedIn · 17 known investors

Find your way into Pivot Bio

403 people in our graph share verified history with the Pivot Bio team — schools, employers, funds. One of them is your warm intro.

Atli Thorkelssonunlockedknows Karsten Temme · together at University of California, Berkeley (overlapped)
×9knows the team · via University of California, Berkeley
knows the team · via Pivot Bio
knows the team · via University of Iowa

Pivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics. The company serves farmers worldwide.

Also known as Pivot Bio, Inc.

Founders & leadership

Pivot Bio was founded in 2011 by Alvin Tamsir and Karsten Temme.

ATAlvin Tamsir
Alvin TamsirinCo-founder · Chief Scientific Officer
KTKarsten Temme
Karsten TemmeinCo-founder · Chief Innovation OfficerCo-founder and Executive Officer of Pivot Bio, an agricultural biotechnology company developing microbial products to reduce synthetic nitrogen use in farming. Temme and co-founder Alvin Tamsir established the company, which now has products deployed across millions of U.S. cropland acres.

Board

RWRoger Wyse
Roger WyseinBoard directorInvestor at Spruce Capital Partners
JHJohn Hamer
John Hamerin𝕏Board directorManaging Partner, DCVC Bio at DCVC (Data Collective)
MOMatt Ocko
Matt Ockoin𝕏Board directorFounder and Managing Partner at DCVC (Data Collective)

Investors · 17

Also in the syndicate · 5

Alan CohenBunge VenturesDCVCleadRockefeller Capital ManagementRoger Underwood

Reported raises · per SEC filings

Form D private placements

$622.6M disclosed across 5 of 6 rounds · 2014–2021

$434.5MraisedAug 2021 · 19 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher AbbottDirector
  • Ryan RakestrawDirector
  • Matt OckoDirector
  • Charles Cooper RinzlerDirector
  • Alvin TamsirExecutive Officer, Director
  • Lisa SafarianDirector
  • Karsten TemmeExecutive Officer, Director
Offering amount
$435M
Amount sold
$434.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100MraisedMay 2020 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Dheeraj MehtaDirector
  • Matt OckoDirector
  • Roger WyseDirector
  • Alvin TamsirExecutive Officer, Director
  • Karsten TemmeExecutive Officer, Director
  • Charles Cooper RinzlerDirector
Offering amount
$100M
Amount sold
$100M
First sale
Jan 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$71.3MraisedOct 2018 · 15 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Roger WyseDirector
  • Karsten TemmeExecutive Officer, Director
  • Alvin TamsirExecutive Officer, Director
  • Dheeraj MehtaDirector
  • Charles Cooper RinzlerDirector
  • Matt OckoDirector
Offering amount
$71.4M
Amount sold
$71.3M
First sale
Sep 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$16MraisedMar 2016 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alvin TamsirExecutive Officer, Director
  • Karsten TemmeExecutive Officer, Director
  • Roger WyseDirector
  • John HamerDirector
  • Matt OckoDirector
Offering amount
$16M
Amount sold
$16M
First sale
Jan 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$750KraisedOct 2014 · 1 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Karsten TemmeExecutive Officer, Director
  • Alvin TamsirExecutive Officer, Director
Offering amount
$1000K
Amount sold
$750K
First sale
Oct 2014
Incorporated
Corporation, Delaware, 2010
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Pivot Bio develops microbial nitrogen products for row crops. Its gene-edited microbes convert atmospheric nitrogen into ammonia directly on a plant's root system, supplying nitrogen through the season as the plant needs it rather than relying solely on soil-applied synthetic fertilizer. The company positions the products as complements to a grower's existing crop nutrition program; PROVEN 40 is stated to replace up to 40 pounds per acre of traditional nitrogen in corn without compromising yield, and the company says farmers can plant seed with up to 25% of the crop's nitrogen needs already in place.

The commercial line spans corn (PROVEN 40, PROVEN G3), wheat and small grains including sorghum, barley, millet, oats and sunflower (RETURN, RETAIN), corn silage, and CERT-N, available in on-seed, in-furrow and dry formulations, with accessory products such as Pivot Bio Extender and NuCore. Products require temperature-controlled dry storage and a single application that fits existing planting equipment; the company provides tank-mix calculators, compatibility guidance and equipment stewardship materials. Pivot Bio also runs the N-OVATOR program, which connects farmers using microbial nitrogen with organizations seeking to reduce on-farm emissions and pays participating growers for improved nitrogen practices.

Founding story

Karsten Temme, Ph.D., is a co-founder and served as CEO, leading the company's development of microbial nitrogen technology as an alternative to synthetic nitrogen fertilizer.

Business model

Pivot Bio manufactures and sells microbial nitrogen products to farmers through a direct-to-grower model rather than traditional fertilizer retail infrastructure, using an on-demand supply chain that ships to growers on their planting timelines. The company has said this approach avoids the factories, pipelines, barges and brick-and-mortar storage associated with synthetic fertilizer, and that advisors can order and schedule delivery via a mobile app.

Revenue comes from sales of microbial nitrogen products (PROVEN, PROVEN 40, PROVEN G3, RETURN, RETAIN, CERT-N) sold per acre to growers, with the company describing recurring, long-term grower relationships. The N-OVATOR program pairs participating farmers with organizations seeking emissions reductions and has paid farmers for improved nitrogen practices.

Traction

Pivot Bio introduced the industry's first commercially available microbial nitrogen in 2019; its inaugural corn product PROVEN sold out in its second commercialization year and was used on hundreds of thousands of U.S. corn acres. In 2021 the company reported use on more than 1 million crop acres, over 300% year-over-year growth, and tripled revenue. The company reports 1,050,000 metric tons of CO2e avoided since 2022 and more than $6 million paid to farmers through the N-OVATOR program since 2022.

Latest developments

In January 2025 the company highlighted a University of Illinois paper describing Pivot Bio as a new source of nitrogen with a unique mode of action, and in January-February 2025 published Northern Plains field results for PROVEN 40 and RETURN OS from the 2024 growing season. The company also notes recognition on TIME magazine's 200 Best Inventions list in two consecutive years and Fast Company's World's Most Innovative Companies of 2024.

Full profile — market position, technology, go-to-market, geography, history

Market position

The company describes the synthetic nitrogen fertilizer market it targets as roughly $190-197 billion globally, and has stated it was the only company shipping a synthetic nitrogen fertilizer replacement at scale and the first to bring commercially available microbial nitrogen to market in 2019, as well as the first to introduce on-seed microbial nitrogen in 2022.

Pivot Bio states its microbes are the only ones on the market that convert atmospheric nitrogen to ammonia directly on the plant root, that PROVEN 40 replaces up to 40 pounds per acre of synthetic nitrogen, and that a University of Illinois study confirmed a unique mode of action. Its direct-to-grower supply chain and single-pass on-seed or in-furrow application are also cited as points of difference versus conventional fertilizer distribution.

Technology

The core technology is gene-edited nitrogen-fixing microbes applied on seed or in-furrow that convert atmospheric nitrogen into ammonia on the plant root, delivering nitrogen through the growing season. The company cites proprietary computational and microbiome technologies and multi-scale automated testing in developing its products, and states that production eliminates 99.5% of greenhouse gas emissions relative to synthetic fertilizer manufacturing.

Go-to-market

Direct-to-grower sales supported by company agronomists, an independent sales representative program, and on-demand shipping tied to planting schedules; earlier expansion used on-farm trial programs, including IN10T FarmerTrials for Canadian growers and an early-adopter program for its first wheat product. Agronomic results from field trials and university research are published on the company site.

Row-crop farmers, primarily U.S. corn growers, plus wheat, small grain (sorghum, barley, millet, oats, sunflower) and corn silage producers.

Geography

Operations centered in the United States, with the company historically headquartered in Berkeley, California and listed at a Berkeley address; agronomy results are reported across the Northern Plains (Minnesota, Montana, North Dakota) and Iowa. The company has stated plans to expand internationally, including availability for Argentinian corn farmers and on-farm trials for Canadian growers.

History

The company launched its first commercially available microbial nitrogen product, PROVEN for corn, in 2019, followed by RETURN for U.S. wheat in spring 2020 through a limited early-adopter program. It closed a $100 million Series C in April 2020 and a $430 million Series D in July 2021, by which point it had released four commercial products in three years, including PROVEN 40. In September 2022 it introduced on-seed microbial nitrogen for corn, grain sorghum and spring wheat, and it launched the N-OVATOR program in 2022.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Acreage growth year-over-yearJan 2021300%
CO2e avoided since 2022Jan 20251,050,000 metric tons
Crop acres using Pivot Bio productsJan 20211,000,000 acres
Global synthetic nitrogen fertilizer market sizeJan 2021$197B
HeadcountAug 2026307
Payments to farmers via N-OVATOR program since 2022Jan 2025$6M
Revenue growthJan 2021Tripled revenue in 2021
Total capital raisedApr 2020$186M
Total equity raisedJul 2021$600M
Yield advantage of PROVEN vs synthetic-only fieldsJan 20195.8 bushels per acre

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Founder mafia

4 people who came through Pivot Bio went on to found or lead other companies.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2015$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Timeline · 8

launches, deals, and filings
Jan 2024
Named to Fast Company's World's Most Innovative Companies 2024

source ↗

Jan 2024
TIME 200 Best Inventions listing for two consecutive years

source ↗

Sep 2022
First-ever on-seed microbial nitrogen introduced

Pivot Bio introduced on-seed microbial nitrogen for crops including corn, grain sorghum and spring wheat.

source ↗

Jul 2021
Pivot Bio closes $430 million Series D

Series D led by DCVC and Temasek, bringing total equity raised to more than $600 million; funds earmarked for scaling the U.S. business and expanding into international markets.

$430M source ↗

Jul 2021
Launch of Pivot Bio PROVEN 40

Second-generation microbial nitrogen product for corn, the company's fourth commercial release in three years, enabling replacement of up to 40 pounds per acre of synthetic nitrogen.

source ↗

Apr 2020
International expansion to Argentina and Canada

Company said PROVEN would soon be available to Argentinian corn farmers and that it would launch on-farm corn trials for Canadian growers via IN10T's FarmerTrials.

source ↗

Apr 2020
Pivot Bio closes $100 million Series C

Series C co-led by returning investors Breakthrough Energy Ventures and Temasek, with DCVC participating materially; company said total raised to date was $186 million.

$100M source ↗

Jan 2020
Pivot Bio RETURN launched for U.S. wheat

Inaugural wheat product introduced through a limited, early-adopter program in spring 2020.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
Pivot BioDelaware

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Pivot Bio do?
Pivot Bio makes gene-edited microbes that fix atmospheric nitrogen on crop roots, replacing part of farmers' synthetic fertilizer.
Who founded Pivot Bio?
Pivot Bio was founded by Alvin Tamsir, Karsten Temme in 2011.
Who are Pivot Bio's investors?
Pivot Bio's investors include Breakthrough Energy Ventures, Congruent Ventures, DCVC (Data Collective), G2 Venture Partners, K3 Ventures, Manta Ray Ventures, Prelude Ventures, Raptor Group and 4 more.
How much funding has Pivot Bio raised?
Pivot Bio has disclosed $622.6M raised across 5 of its 6 known rounds.
Where is Pivot Bio headquartered?
Pivot Bio is headquartered in Emeryville, US.